Ferring Makes Important Milestone For Microbiome With Rebyota Approval

 
• By Alaric DeArment
  
The FDA approved Ferring's microbiome drug, Rebyota, for preventing recurrence of C. difficile infections • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip